Gedera, Israel

Hila Isenberg

This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hila Isenberg. Retrieved from https://idiyas.com/inventor/hila-isenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hila Isenberg: Innovator in Letrozole Purification

Introduction

Hila Isenberg is a notable inventor based in Gedera, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the purification of letrozole, a medication used in the treatment of breast cancer. Her innovative approach has led to the development of a unique purification process that enhances the quality of letrozole products.

Latest Patents

Hila Isenberg holds 1 patent for her work on the "Letrozole purification process." This patent outlines a method for purifying a letrozole product that contains an isoletrozole impurity. The process involves converting a portion of the isoletrozole impurity into 4,4'-dicyanobenzophenone and subsequently removing this compound to yield a purified letrozole product.

Career Highlights

Hila Isenberg is associated with Chemagis Ltd., where she applies her expertise in pharmaceutical development. Her work has been instrumental in improving the efficacy and safety of letrozole, contributing to better treatment options for patients.

Collaborations

Hila collaborates with talented professionals in her field, including Michal Hasson and Efrat Manoff. These partnerships enhance the innovative capacity of her projects and foster a collaborative environment for research and development.

Conclusion

Hila Isenberg's contributions to the purification of letrozole exemplify her commitment to advancing pharmaceutical science. Her innovative processes not only improve product quality but also have a significant impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…